Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Abdullah M. Aldalaan"'
Autor:
Yousif S. Alakeel, Emmanouil Rampakakis, Ali AlRumaih, Rana AlRuwaisan, Maha Abushal, Abdullah M. AlDalaan, Majdy M. Idrees, Zaid D. Alanazi, Hanouf AlKoait, Abdulrahman Muaadi, Majed Ali M. AlAfra, Shaya A. AlShaya, Suliman AlHomida
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
In an era of cost pressure, substituting generic drugs represents one of the main cost-containment strategies of healthcare systems. Despite the obvious financial benefits, in a minority of cases, substitution may require caution or even be contraind
Externí odkaz:
https://doaj.org/article/7403bfa8853c455796985dae8b686340
Autor:
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Even though pulmonary arterial hypertension (PAH) remains an incurable disease, the combination of PAH‐specific therapies allowed treatment strategies to evolve from symptom‐based ones to others that aim to move patients to low‐risk co
Externí odkaz:
https://doaj.org/article/2e65aa03b08144ce8bb3afcfa69d277c
Autor:
Abdullah M. Aldalaan, Khushnooda Ramzan, Sarfraz A. Saleemi, Ihab Weheba, Laila Alquait, Abeer Abdelsayed, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi, Mohammed Al-Owain, Faiqa Imtiaz
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Pulmonary arterial hypertension (PAH), whether idiopathic PAH (IPAH), heritable PAH, or associated with other conditions, is a rare and potentially lethal disease characterized by progressive vascular changes. To date, there is limited data on the ge
Externí odkaz:
https://doaj.org/article/ec4b63c248e24273b81cf5dc71462595
Autor:
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Pekka Hämmäinen, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive vascular disease with poor prognosis if left untreated. This study aims to assess the patient characteristics, treatment approach and clinical and survival outcom
Externí odkaz:
https://doaj.org/article/38852f77969d43879e4b1469ea5ed435
Autor:
Fatima Alzubi, Abeer Abdelsayed, Ihab Weheba, Abdullah M. Aldalaan, Maha Al-Eid, Sarfraz Saleemi, Nadeen Alharbi, Hamdeia Zaytoun
Publikováno v:
Respirology. 26:92-101
BACKGROUND AND OBJECTIVE This study presents the first results of 'SAUDIPH' registry, aiming to assess patient characteristics, treatment approach and clinical and survival outcomes in patients with PAH. METHODS The registry enrolled patients with Gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b108e7246a6d4499b66b62aacf83456b
https://doi.org/10.1111/resp.13879
https://doi.org/10.1111/resp.13879
Autor:
Pekka Hämmäinen, Fatima Alzubi, Maha Al-Eid, Abdullah M. Aldalaan, Sarfraz Saleemi, Abeer Abdelsayed, Ihab Weheba, Nadeen Alharbi, Hamdeia Zaytoun
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research
article-version (VoR) Version of Record
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive vascular disease with poor prognosis if left untreated. This study aims to assess the patient characteristics, treatment approach and clinical and survival outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4572773a617e5be6c6659a9c8a1e0e
https://doi.org/10.1183/23120541.00218-2019
https://doi.org/10.1183/23120541.00218-2019
Autor:
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi
Publikováno v:
Pulmonary circulation. 12(2)
Even though pulmonary arterial hypertension (PAH) remains an incurable disease, the combination of PAH-specific therapies allowed evolving from symptom-based strategies to others aiming to move patients to low-risk conditions. Endothelin-1 (ET-1) rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103a92e58af2e18b17cb0598e01d97df
https://pubmed.ncbi.nlm.nih.gov/35514768
https://pubmed.ncbi.nlm.nih.gov/35514768
Autor:
Laila AlQuait, Abdullah M. Aldalaan, Mohammed Al-Owain, Khushnooda Ramzan, Nadeen Alharbi, Hamdeia Zaytoun, Ihab Weheba, Abeer Abdelsayed, Fatima Alzubi, Sarfraz Saleemi, Faiqa Imtiaz
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 11 (2021)
Pulmonary Circulation, Vol 11 (2021)
Pulmonary arterial hypertension (PAH), whether idiopathic PAH (IPAH), heritable PAH, or associated with other conditions, is a rare and potentially lethal disease characterized by progressive vascular changes. To date, there is limited data on the ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6be3bb259d02f3bae60aa0b0ddfab8bf
https://pubmed.ncbi.nlm.nih.gov/34377436
https://pubmed.ncbi.nlm.nih.gov/34377436
Publikováno v:
Pulmonary hypertension.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef929af5bcf1c01eafe449e928c2da80
https://doi.org/10.1183/13993003.congress-2018.oa3279
https://doi.org/10.1183/13993003.congress-2018.oa3279
Publikováno v:
Journal of Bronchology. 14:127-128
We present, for the first time to our knowledge, chylothorax after transbronchial fine needle aspiration in a patient with mediastinal lymphadenopathy secondary to tuberculosis. The patient recovered fully with conservative measures. We also discuss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::029380655b0257df5b2723491340e3e9
https://doi.org/10.1097/lbr.0b013e31803db6fc
https://doi.org/10.1097/lbr.0b013e31803db6fc